loadpatents
name:-0.019805908203125
name:-0.012423038482666
name:-0.20776009559631
Bates; Susan E. Patent Filings

Bates; Susan E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bates; Susan E..The latest application filed is for "non-hydrolyzable non-cleavable, stable linkers for precision therapeutics and uses thereof".

Company Profile
0.13.17
  • Bates; Susan E. - New York NY
  • Bates; Susan E. - Bethesda MD
  • Bates; Susan E. - Rockville MD
  • Bates, Susan E - Bethesda MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Non-hydrolyzable Non-cleavable, Stable Linkers For Precision Therapeutics And Uses Thereof
App 20220251143 - Fojo; Antonio Tito ;   et al.
2022-08-11
Method of inhibiting ABCG2 and related treatments
Grant 9,937,217 - Henrich , et al. April 10, 2
2018-04-10
Method of inhibiting ABCG2 and other treatment methods
Grant 9,314,448 - Henrich , et al. April 19, 2
2016-04-19
Deacetylase inhibitor therapy
Grant 9,259,452 - McCulloch , et al. February 16, 2
2016-02-16
Method Of Inhibiting Abcg2 And Related Treatments
App 20150342978 - Henrich; Curtis J. ;   et al.
2015-12-03
Method of inhibiting ABCG2 and related treatments
Grant 9,114,102 - Henrich , et al. August 25, 2
2015-08-25
Deacetylase Inhibitor Therapy
App 20150182585 - MCCULLOCH; William ;   et al.
2015-07-02
Deacetylase inhibitor therapy
Grant 8,957,027 - McCulloch , et al. February 17, 2
2015-02-17
Depsipeptide for therapy of kidney cancer
Grant 8,673,888 - Naoe , et al. March 18, 2
2014-03-18
Method Of Inhibiting Abcg2 And Other Treatment Methods
App 20130274323 - Henrich; Curtis J. ;   et al.
2013-10-17
Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer
Grant 8,470,888 - Henrich , et al. June 25, 2
2013-06-25
Methods For Increasing Levels Of Human Fetal Hemoglobin
App 20130123184 - KEEGAN; Mitchell ;   et al.
2013-05-16
Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
Grant 8,273,797 - Mertins , et al. September 25, 2
2012-09-25
Treating Renal Cancer Using A 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde
App 20110269840 - Mertins; Susan D. ;   et al.
2011-11-03
Methods For Increasing Levels Of Human Fetal Hemoglobin
App 20110015168 - Keegan; Mitchell ;   et al.
2011-01-20
Method Of Inhibiting Abcg2 And Other Treatment Methods
App 20100317732 - Henrich; Curtis J. ;   et al.
2010-12-16
Method Of Inhibiting Abcg2 And Related Treatments
App 20100267652 - Henrich; Curtis J. ;   et al.
2010-10-21
Materials And Methods For Abcb1 Polymorphic Variant Screening, Diagnosis, And Treatment
App 20090325156 - Figg; William D. ;   et al.
2009-12-31
Treating or Preventing Renal Cancer Using a Dimethane Sulfonate
App 20090131536 - Mertins; Susan D. ;   et al.
2009-05-21
Topical Formulations of Histone Deacetylase Inhibitors and Methods Using the Same
App 20080292616 - Bates; Susan E. ;   et al.
2008-11-27
Deacetylase Inhibitor Therapy
App 20080124403 - McCulloch; William ;   et al.
2008-05-29
ATP-binding cassette protein responsible for cytotoxin resistance
App 20070048810 - Dean; Michael ;   et al.
2007-03-01
ATP-binding cassette protein responsible for cytotoxin resistance
Grant 7,138,493 - Dean , et al. November 21, 2
2006-11-21
Depsipeptide for therapy of kidney cancer
App 20060135413 - Naoe; Yoshinori ;   et al.
2006-06-22
Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell
App 20040259772 - Fojo, Antonio ;   et al.
2004-12-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed